Trade Names: | |
Synonyms: | |
Status: | Approved (1972) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | C05AA06 |
UNII: | SV0CSG527L |
InChI Key | FAOZLTXFLGPHNG-KNAQIMQKSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C22H29FO4 |
Molecular Weight | 376.47 |
AlogP | 2.92 |
Hydrogen Bond Acceptor | 4.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 1.0 |
Polar Surface Area | 74.6 |
Molecular species | NEUTRAL |
Aromatic Rings | 0.0 |
Heavy Atoms | 27.0 |
Primary Target | |
---|---|
Glucocorticoid receptor |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 1
Nuclear hormone receptor subfamily 1 group I
Nuclear hormone receptor subfamily 1 group I member 2
|
1300-12600 | - | - | - | - | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 106 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Dry Eye Syndromes | 3 | D015352 | ClinicalTrials |
Corneal Opacity | 2 | D003318 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 426-13-1 |
ChEBI | 31625 |
ChEMBL | CHEMBL1200600 |
DrugBank | DB00324 |
DrugCentral | 1208 |
EPA CompTox | DTXSID7047435 |
FDA SRS | SV0CSG527L |
Human Metabolome Database | HMDB0014469 |
Guide to Pharmacology | 7079 |
PharmGKB | PA164781355 |
PubChem | 9878 |
SureChEMBL | SCHEMBL5051 |
ZINC | ZINC000118912517 |